MX9701532A - Procedimiento para aumentar los niveles de testosterona. - Google Patents

Procedimiento para aumentar los niveles de testosterona.

Info

Publication number
MX9701532A
MX9701532A MX9701532A MX9701532A MX9701532A MX 9701532 A MX9701532 A MX 9701532A MX 9701532 A MX9701532 A MX 9701532A MX 9701532 A MX9701532 A MX 9701532A MX 9701532 A MX9701532 A MX 9701532A
Authority
MX
Mexico
Prior art keywords
methyl
same
ethyl group
testosterone
different
Prior art date
Application number
MX9701532A
Other languages
English (en)
Other versions
MXPA97001532A (es
Inventor
David B Maclean
David D Thomposon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9701532A publication Critical patent/MX9701532A/es
Publication of MXPA97001532A publication Critical patent/MXPA97001532A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invencion proporciona nuevos procedimientos para aumentar los niveles séricos de testosterona que comprenden administrar a un mamífero en necesidad de dicho tratamiento, una cantidad eficaz de un compuesto de formula (I) en la que R1 y R2 pueden ser iguales o distintos a condicion de que, cuando R1 y R2 son iguales, cada uno es un grupo metilo o etilo y, cuando R1 y R2 son diferentes, uno de ellos es un grupo metilo o etilo y el otro es hidrogeno o un grupo bencilo; o una de sus sales farmacéuticamente eceptables.
MXPA/A/1997/001532A 1996-02-28 1997-02-27 Procedimiento para aumentar los niveles de testosterona MXPA97001532A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2118196P 1996-02-28 1996-02-28
US60/021,181 1996-02-28

Publications (2)

Publication Number Publication Date
MX9701532A true MX9701532A (es) 1998-06-30
MXPA97001532A MXPA97001532A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
CA2198535A1 (en) 1997-08-28
CN1165649A (zh) 1997-11-26
IL120262A0 (en) 1997-06-10
JPH09315962A (ja) 1997-12-09
AU1496697A (en) 1997-09-04
EP0793961A1 (en) 1997-09-10
US6017964A (en) 2000-01-25
CA2198535C (en) 2000-06-20
IL120262A (en) 2001-01-28
AU712800B2 (en) 1999-11-18
ZA971709B (en) 1998-08-27

Similar Documents

Publication Publication Date Title
CA2198535A1 (en) Method of increasing testosterone
CA2245142A1 (en) New phenanthridines
AU7578894A (en) Methods for inhibiting smooth muscle cell proliferation and restinosis
CA2289717A1 (en) Novel therapy for constipation
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
TR200202323T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
HK1029922A1 (en) Angiostatic agents and compositions for treating glc1a glaucoma
HK1028568A1 (en) Alpha-ketoamide multicatalytic protease inhibitors
MX9706957A (es) Composicion que contiene amlodipina, o una sal, o felodipina y un inhibidor de enzima convertidora de angiotensina.
CA2198580A1 (en) Combination therapy to treat osteoporosis
MX9709466A (es) Medicamento para inhibir el melanoma.
CA2267945A1 (en) Anticonvulsant derivatives useful in treating neuropathic pain
NO984920D0 (no) Sammensetninger omfattende en nitroneforbindelse for anvendelse ved behandling av okulµr inflammasjon
PL322763A1 (en) Levobupivacaine and pplication thereof as anelgetic agent for pregnant women
BG101884A (en) Salts of the clavulanic acid
MX9701606A (es) Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno.
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
MY113406A (en) Methods of inhibiting physiological conditions associated with an excess of bradykinin
ZA949564B (en) Method for treating constipation using dimeticone.
BG101325A (en) Use of muramyl peptide compounds
MX9701529A (es) Uso de (e)-1-[4'-(2-alquilaminoetoxi)fenil]-1-(3'-hidroxifenil)-2-f enilbut-1-enos para inhibir trastornos patologicos.
TW340108B (en) 1,1-difluoro-1,4-dichlorobutane and process for its preparation
CY2582B2 (en) New imidazopyridines and oxazolopyridines
AU4448497A (en) Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents